Philadelphia 2022 Q3 News Recap – Cellicon Valley Continues to Showcase Strengths

Published on :

According to the recent Life Sciences Research Outlook & Cluster Rankings report from JLL, the Greater Philadelphia region has advanced four positions in the Life Sciences Cluster Composition Matrix, which measures how each market stacks up in terms of human and physical capital. The regional improvement was due to increased and steady funding supporting the specialization of cell and gene therapy research being conducted in the area, which comes as no surprise as these therapies continue to become increasingly important options in disease treatment.

LucasPye BIO CEO Dr. Tia Lyles-Williams Ready to Support White House Biomanufacturing Initiative

Published on :

Dr. Tia Lyles-Williams, Chief Executive Officer of Philadelphia-based LucasPye Bio (LPB), a biologics contract development and manufacturing organization (CDMO), is ready to embrace the work ahead in order to expand opportunities for her company, as well as for other biomanufacturing organizations across the country.

C-Suite Women in Greater Philly’s Life Science Scene You Should Know

Published on :

As long overdue change takes shape and the number of women in the biotech industry continues to grow, it is important to recognize those that have created the path for the next generation of diverse leaders. BioBuzz wishes to acknowledge the incredible contributions and efforts of women who have made their mark on the industry. 

Could Philadelphia Become a Destination for Equity-Minded Life Sciences Training?

Published on :

Philadelphia has seen a 127% increase in cell and gene therapy employment since 2019.
That eye-popping stat comes from the University City Science Center’s 2022 report Greater Philadelphia Cell and Gene Therapy Workforce Update, a follow up to the 2020 Cell and Gene Therapy and Connected Health Workforce Analysis study. It translates to potentially thousands of open roles in the region known by the branding obsessed as Cellicon Valley.
And yet, that stat doesn’t necessarily mean Philadelphians in need of wages that would support a higher quality of life are trained for those available life science jobs — or even know they exist.
A Friday morning panel called “Workforce Development in the Life Sciences: Building Skills, Diversity and Education in Philadelphia and Beyond” during the 2022 B.PHL Innovation Fest dove into the barriers and opportunities for the life science industry’s workforce.
Phil Brooks, director of STEM workforce partnerships at the Science Center, and Tia Lyles-Williams, founder and CEO of both LucasPye Bio and HelaPlex, both sat on the panel moderated by Lauren Swartz, president and CEO of the World Affairs Council of Philadelphia.
Brooks’ work centers on exposure to professional opportunities through workforce development programs. Lyles-Williams said HelaPlex, a forthcoming Philly life…

White House Summit on Biotechnology and Biomanufacturing

Published on :

The White House Summit on
Biotechnology and Biomanufacturing will include three (3) sessions, where participants will exchange views on the opportunities for biotechnology and biomanufacturing to advance the American economy and U.S. global leadership in this critical technology.

How Life Sciences Companies Can Successfully Execute and Sustain Diversity, Equity, and Inclusion (DE&I) Initiatives

Published on :

The life sciences industry is booming in our region and globally, which has put the need for more biotech talent in the spotlight. This urgent need for talent has finally made diversity and inclusion part of every discussion about talent acquisition and workforce development. Companies large and small are starting to take action to ensure their workforce demographics are right-sized to match a diverse workforce population. 

LucasPye and IndyGeneUS AI Forge Partnership To Address Drug Development and the African Diaspora

Published on :

Over the years, minority input in the clinical development of life-saving drugs has been lacking, particularly when it comes to clinical trial participation. That has led to disparities in the efficacy of medications when taken by minority

Philadelphia-based LucasPye Bio announces first contract manufacturing partnership

Published on :

LucasPye Bio, a Philadelphia biologics contract development and manufacturing organization, has formed a partnership with Africa-based genomics company IndyGeneUS AI aimed at advancing targeted therapeutics focused on health disparities.